IRIS
VENERITO, VINCENZO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.406
EU - Europa 377
AS - Asia 164
OC - Oceania 2
SA - Sud America 2
AF - Africa 1
Totale 1.952
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.404
SE - Svezia 150
IT - Italia 92
CN - Cina 73
SG - Singapore 60
FR - Francia 33
DE - Germania 32
GB - Regno Unito 23
IN - India 16
BE - Belgio 13
CZ - Repubblica Ceca 11
FI - Finlandia 9
UA - Ucraina 6
IR - Iran 4
VN - Vietnam 4
ID - Indonesia 3
JP - Giappone 3
AU - Australia 2
BR - Brasile 2
CA - Canada 2
PT - Portogallo 2
AT - Austria 1
EG - Egitto 1
ES - Italia 1
HR - Croazia 1
IE - Irlanda 1
IS - Islanda 1
RO - Romania 1
TW - Taiwan 1
Totale 1.952
Salva come PNG Salva come JPEG
Città #
Chandler 198
Fairfield 183
Nyköping 136
Ashburn 115
Woodbridge 81
Houston 74
Cambridge 71
Seattle 65
Wilmington 49
Ann Arbor 43
Singapore 40
New York 33
Lawrence 32
Roxbury 30
Bari 26
Beijing 25
Inglewood 25
Jacksonville 21
Des Moines 19
Munich 15
Pune 14
Brussels 13
Los Angeles 13
Brno 9
Helsinki 9
San Diego 9
Santa Clara 8
Nanjing 7
Shanghai 7
Paris 6
Redwood City 6
Brindisi 5
Florence 5
London 5
Shenyang 5
Brooklyn 4
Dearborn 4
Dong Ket 4
Hounslow 4
Modugno 4
San Francisco 4
Ardabil 3
Boardman 3
Milan 3
New Bedfont 3
Ostwald 3
Princeton 3
Tianjin 3
Washington 3
Wuhan 3
Augusta 2
Avegno 2
Guangzhou 2
Hefei 2
Leawood 2
Massa 2
Melbourne 2
Olomouc 2
Prescot 2
San Mateo 2
Toronto 2
Bitonto 1
Cairo 1
Cerignola 1
Chapel Hill 1
Chicago 1
Chiswick 1
Chizhou 1
Clifton 1
Dallas 1
Dublin 1
Fort Worth 1
Giovinazzo 1
Haikou 1
Harbin 1
Hebei 1
Jakarta 1
Kilburn 1
Madrid 1
Marseille 1
Monmouth Junction 1
Mountain View 1
Mumbai 1
Nagold 1
Norwalk 1
Oklahoma City 1
Reykjavik 1
Rome 1
Sandston 1
Sanming 1
Southwark 1
Springfield 1
Taipei 1
Taranto 1
Triggiano 1
Vienna 1
Wandsworth 1
Totale 1.511
Salva come PNG Salva come JPEG
Nome #
Unveiling the Efficacy, Safety, and Tolerability of Anti-Interleukin-1 Treatment in Monogenic and Multifactorial Autoinflammatory Diseases 107
A Bayesian mixed treatment comparison of efficacy of biologics and small molecules in early rheumatoid arthritis 106
Ten-Year Retention Rate of Infliximab in Patients with Behçet's Disease-Related Uveitis 104
Adalimumab Accounts for Long-Term Control of Noninfectious Uveitis Also in the Absence of Concomitant DMARD Treatment: A Multicenter Retrospective Study 97
AB0836 Drug retention rate of the first tnf inhibitor in radiographic and non radiographic axial spondyloarthritis: data from a multicenter study 90
AB0041 Serum Amyloid A Stimulates The Induction of Inflammatory Mediators in Monocytes from Behçet's Disease Patients: A Proof of Concept Study 84
Splenic Infarction as Only Manifestation of Antiphospholipid Syndrome in a Patient With Rheumatoid Arthritis 80
Critical regulation of Th17 cell differentiation by serum amyloid-A signalling in Behcet's disease 71
null 71
AB0245 PREDICTORS OF BIOLOGIC THERAPY DISCONTINUATION IN RHEUMATOID ARTHRITIS PATIENTS AFTER REMISSION ACHIEVEMENT: A MONOCENTRIC OBSERVATIONAL STUDY FROM BIOLOGIC APULIAN REGISTRY (BIOPURE) 68
THU0168 Relationships between body fat composition assessed with bioelectrical impedance analysis, serum adipokines and disease activity in patients with rheumatoid arthritis 60
Epidemiological profile of non-infectious uveitis from the rheumatologist's perspective: a survey from two tertiary referral centres in Italy 57
A machine learning tool to predict the response to neoadjuvant chemotherapy in patients with locally advanced cervical cancer 49
Different drug survival of first line tumour necrosis factor inhibitors in radiographic and non-radiographic axial spondyloarthritis: a multicentre retrospective survey 48
Influence of changes in cholesterol levels and disease activity on the 10 years cardiovascular risk estimated with different algorithms in rheumatoid arthritis patients 46
The autoinflammatory side of recurrent pericarditis: Enlightening the pathogenesis for a more rational treatment 46
Efficacy of baricitinib on refractory skin papulosquamous rash in a patient with systemic lupus erythematosus 44
Effectiveness and safety profile of anakinra in a HLA-B27 positive patient with multiple sclerosis-associated uveitis 44
The Impact of Biologic Drugs on High-Density Lipoprotein Cholesterol Efflux Capacity in Rheumatoid Arthritis Patients 42
Real-world effectiveness of apremilast in multirefractory mucosal involvement of Behçet's disease 41
Diagnostic accuracy of a velcro sound detector (VECTOR) for interstitial lung disease in rheumatoid arthritis patients: the InSPIRAtE validation study (INterStitial pneumonia in rheumatoid ArThritis with an electronic device) 40
Tomographic regression of pulmonary rheumatoid nodules under baricitinib therapy 39
Formalin-fixed and paraffin-embedded samples for next generation sequencing: Problems and solutions 35
Immunogenicity of BNT162b2 mRNA SARS-CoV-2 vaccine in patients with psoriatic arthritis on TNF inhibitors 35
Risk of acute arterial and venous thromboembolic events in Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss syndrome) 34
Adalimumab effectively controls both anterior and posterior noninfectious uveitis associated with systemic inflammatory diseases: focus on Behçet’s syndrome 34
Long-term safety of rituximab in rheumatic patients with previously resolved hepatitis B virus infection 30
High disease relapse after bDMARD spacing in psoriatic arthritis compared to rheumatoid arthritis and axial spondyloarthritis patients: real-life data from BIOPURE registry 28
Cardiovascular risk estimation with 5 different algorithms before and after 5 years of bDMARD treatment in rheumatoid arthritis 28
Safety of systemic treatments for Behçet’s syndrome 25
Comorbid fibromyalgia impairs the effectiveness of biologic drugs in patients with psoriatic arthritis 24
Long-term effectiveness and safety of switching from originator to biosimilar infliximab in patients with Behçet’s disease 23
null 22
Radiomics analysis in ovarian cancer: A narrative review 22
A convolutional neural network with transfer learning for automatic discrimination between low and high-grade synovitis: a pilot study 19
Complete Hydatidiform Mole Mimicking Sacroiliitis 17
Management of takayasu arteritis diagnosed during pregnancy: A case report 16
Validity of Machine Learning in Predicting Giant Cell Arteritis Flare After Glucocorticoids Tapering 16
Exploring the oral microbiome in rheumatic diseases, state of art and future prospective in personalized medicine with an ai approach 16
A Machine Learning Approach to Predict Remission in Patients With Psoriatic Arthritis on Treatment With Secukinumab 14
Development and preliminary validation of the Behçet’s syndrome Overall Damage Index (BODI) 13
Machine learning applied to MRI evaluation for the detection of lymph node metastasis in patients with locally advanced cervical cancer treated with neoadjuvant chemotherapy 11
Anakinra effectiveness in refractory polyserositis: An Italian multicenter study 11
Comparison of Adalimumab to Other Targeted Therapies in Rheumatoid Arthritis: Results from Systematic Literature Review and Meta-Analysis 11
Predictors of long-term clinical remission in rheumatoid arthritis 10
Efficacité de l'anakinra dans la polysérite réfractaire : étude multicentrique italienne 9
Safety Profile and Low Risk of Disease Relapse After BNT162b2 mRNA SARS-CoV-2 Vaccination in Patients With Rare Rheumatic Diseases 9
Cytokine signatures in mucocutaneous and Ocular Behçet's disease 8
Anti-SARS-CoV-2 antibody decay after vaccination and immunogenicity of the booster dose of the BNT162b2 mRNA vaccine in patients with psoriatic arthritis on TNF inhibitors 8
A Machine Learning Approach for Predicting Sustained Remission in Rheumatoid Arthritis Patients on Biologic Agents 8
Effectiveness of biological targeted therapies may discriminate seronegative from seropositive rheumatoid arthritis 8
Serum sCD40L levels are increased in patients with psoriatic arthritis and are associated with clinical response to apremilast 8
COVAD survey 2 long-term outcomes: unmet need and protocol 8
Letters to the editors 8
Immunogenicity and Safety of Adjuvanted Recombinant Zoster Vaccine in Rheumatoid Arthritis Patients on Anti-Cellular Biologic Agents or JAK Inhibitors: A Prospective Observational Study 8
Erratum: Efficacy of baricitinib on refractory skin papulosquamous rash in a patient with systemic lupus erythematosus (Rheumatology (2020) 59 (1188) DOI: 10.1093/rheumatology/kez442) 8
Histopathologic Features of Fibrotic Knee Synovitis in a Young Adult with Seronegative Rheumatoid Arthritis 7
Safety and effectiveness in switching from reference to biosimilar rituximab in rheumatoid arthritis patients: real world experience from a single Italian rheumatology centre 7
Discordance between patient and physician global assessment of disease activity in Behçet’s syndrome: a multicenter study cohort 6
Paradoxical Pustular Psoriasis in a Patient with Psoriatic Arthritis on Secukinumab Treatment 5
Explainable artificial intelligence for microbiome data analysis in colorectal cancer biomarker identification 5
Safety profile and SARS-CoV-2 breakthrough infections among HCWs receiving anti-SARS-CoV-2 and influenza vaccines simultaneously: an Italian observational study 4
Tocilizumab therapy in rheumatoid arthritis with interstitial lung disease: a multicentre retrospective study 4
COVID-19, rheumatic diseases and immunosuppressive drugs: an appeal for medication adherence 4
AI am a rheumatologist: A practical primer to large language models for rheumatologists 4
Rheumatoid Arthritis from Easy to Complex Disease: From the “2022 GISEA International Symposium” 4
Extra-Articular Manifestations and Comorbidities in Psoriatic Disease: A Journey Into the Immunologic Crosstalk 3
COVID-19 Vaccine Knowledge, Attitude, Acceptance and Hesitancy among Pregnancy and Breastfeeding: Systematic Review of Hospital-Based Studies 3
Evolution of Rheumatoid-Arthritis-Associated Interstitial Lung Disease in Patients Treated with JAK Inhibitors: A Retrospective Exploratory Study 3
Unraveling the microbiome-metabolome nexus: a comprehensive study protocol for personalized management of Behḉet’s disease using explainable artificial intelligence 3
The Use and Utility of Machine Learning in Achieving Precision Medicine in Systemic Sclerosis: A Narrative Review 3
Safety profile of recombinant adjuvanted anti-herpes zoster vaccine (RZV) in high-risk groups: Data from active surveillance program. Puglia (Italy), 2021-23 2
Retention rate of a second line with a biologic DMARD after failure of a first-line therapy with abatacept, tocilizumab, or rituximab: results from the Italian GISEA registry 2
Higher risk of short term COVID-19 vaccine adverse events in myositis patients with autoimmune comorbidities: results from the COVAD study 2
Histopathological characteristics of synovitis in Familial Mediterranean Fever (FMF) 2
Uncovering the Underworld of Axial Spondyloarthritis 2
Integrating large language models in medicine: a study of Claude 2’s performance in MDAAT scoring for idiopathic inflammatory myopathies 2
Safety of abatacept in Italian patients with rheumatoid arthritis and interstitial lung disease: A multicenter retrospective study 2
Update on the Medical Management of Gastrointestinal Behçet's Disease 1
Fibrosing Progressive Interstitial Lung Disease in Rheumatoid Arthritis: A Multicentre Italian Study 1
Harnessing the potential of digital rheumatology 1
Reply to Praprotnik and Tomsic and erratum corrige 1
Prompt engineering: The next big skill in rheumatology research 1
Radiomics to predict the mortality of patients with rheumatoid arthritis-associated interstitial lung disease: A proof-of-concept study 1
Totale 2.103
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.644
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.644
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020343 0 0 5 25 29 37 44 46 54 37 45 21
2020/2021324 16 26 41 10 23 29 35 39 23 34 29 19
2021/2022264 9 5 5 8 10 22 23 10 22 35 46 69
2022/2023589 48 86 32 32 41 111 13 83 92 4 33 14
2023/2024320 22 55 18 28 29 67 5 27 3 13 5 48
2024/2025129 45 29 55 0 0 0 0 0 0 0 0 0
Totale 2.103